Literature DB >> 16180058

A practical approach to developing cases for standardized patients.

K E Olive1, D M Elnicki, M J Kelley.   

Abstract

This article outlines a process for developing standardized patient cases. The initial step in the process is to define the educational goals of the exercise. Following this step the patient characteristics, setting for the interaction and clinical information are developed. Clinical information, in addition to history, may include elements of nonverbal communication, actual or simulated abnormal physical findings, and laboratory results. Guidelines for the standardized patient regarding disclosure of information to the student and providing feedback to the student enhance the value of the case. If the case is to be used as part of an examination, a grading system must be developed. Issues of cost, validity, and reliability are briefly addressed.

Entities:  

Year:  1997        PMID: 16180058     DOI: 10.1023/A:1009704030279

Source DB:  PubMed          Journal:  Adv Health Sci Educ Theory Pract        ISSN: 1382-4996            Impact factor:   3.853


  4 in total

1.  [Practical examinations for neurology. The Tuebingen model].

Authors:  M Schrauth; N Schmulius; S Zipfel; T Haarmeier
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

2.  [Clinical teaching with simulated patients in psychiatry and psychotherapy. A controlled pilot study].

Authors:  M Wündrich; J Peters; A Philipsen; M Kopasz; M Berger; U Voderholzer
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

3.  A Curriculum Innovation on Writing Simulated Patient Cases for Communication Skills Education.

Authors:  April R Christensen; Carla L Spagnoletti; Rene N Claxton
Journal:  MedEdPORTAL       Date:  2021-01-12

4.  On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.

Authors:  Jemima A Frimpong; Thomas D'Aunno; David C Perlman; Shiela M Strauss; Alissa Mallow; Diana Hernandez; Bruce R Schackman; Daniel J Feaster; Lisa R Metsch
Journal:  Trials       Date:  2016-03-03       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.